Clinical trial
Cystagon to Treat Infantile Neuronal Ceroid Lipofuscinosis
NCT00028262 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Completed
Key facts
| NCT number | NCT00028262 |
|---|---|
| Title | Cystagon to Treat Infantile Neuronal Ceroid Lipofuscinosis |
| Official title | A Combination Therapy With Cystagon and N-Acetylcysteine for INCL Patients |
| Lead sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Infantile Neronal Ceroid Lipofuscinosis |
| Intervention type | Drug |
| Interventions | Cystagon |
| Enrollment | 10 |
| Start date | Feb 1, 2001 |
| Primary completion | Nov 1, 2013 |
| Completion | Nov 1, 2013 |
| First posted | Dec 18, 2001 |
| Last update posted | Oct 27, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: